PEGylation of bacteriophages increases blood circulation time and reduces T-helper type 1 immune response

Microbial Biotechnology

Volumn 1, Issue 3, 2008, Pages 247-257

  Kim, Kwang Pyo ^a   Cha, Jeong Dan ^b   Jang, Eun Hye ^b   Klumpp, Jochen ^a   Hagens, Steven ^a   Hardt, Wolf Dietrich ^a   Lee, Kyung Yeol ^b   Loessner, Martin J ^a  

^a ETH ZURICH   (Switzerland)

^b Chonbuk National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 6; MACROGOL; VIRUS PROTEIN;

ARTICLE; BACTERIAL GENOME; BACTERIAL INFECTION; BACTERIOPHAGE; BACTERIUM CONJUGATION; CELLULAR IMMUNITY; CHEMICAL REACTION; CIRCULATION TIME; CONTROLLED STUDY; COVALENT BOND; CYTOKINE RELEASE; IMMUNE RESPONSE; IMMUNOGENICITY; INNATE IMMUNITY; LISTERIA; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; SALMONELLA; TH1 CELL; VIRUS INFECTIVITY;

ANIMALS; BIOLOGICAL THERAPY; BLOOD CIRCULATION; DISEASE MODELS, ANIMAL; HUMANS; LISTERIA; LISTERIOSIS; MALE; MICE; MICE, INBRED BALB C; MYOVIRIDAE; POLYETHYLENE GLYCOLS; SALMONELLA INFECTIONS; SALMONELLA TYPHIMURIUM; T-LYMPHOCYTES, HELPER-INDUCER; TIME FACTORS;

LISTERIA; MUS; MYOVIRIDAE; SALMONELLA;

EID: 77950115105     PISSN: 17517907     EISSN: 17517915     Source Type: Journal    
DOI: 10.1111/j.1751-7915.2008.00028.x     Document Type: Article

References (36)

1. Abuchowski, A., McCoy, J.R., Palczuk, N.C., van Es, T., and Davis, F.F. (1977a) Effect of covalent attachment of polyethylene glycol on immunogenicity and circulating life of bovine liver catalase. J Biol Chem 11: 3582-3586.
2. Abuchowski, A., van Es, T., Palczuk, N.C., and Davis, F.F. (1977b) Alteration of immunological properties of bovine serum albumin by covalent attachment of polyethylene glycol. J Biol Chem 11: 3578-3581.
3. Ackermann, H.W., and Nguyen, T.M. (1983) Sewage coliphages studied by electron microscopy. Appl Environ Microbiol 45: 1049-1059.
4. Adams, M.H. (1959) Methods of study of bacterial viruses. In Bacteriophages. Hershey, A.D. (ed.). New York, NY, USA: Interscience Publishers, pp. 443-457.
5. Alemany, R., Suzuki, K., and Curiel, D.T. (2000) Blood clearance rates of adenovirus type 5 in mice. J Gen Virol 81: 2605-2609.
6. Bode, H.J. (1976) SDS-polyethyleneglycol electrophoresis: a possible alternative to SDS-polyacrylamide gel electrophoresis. FEBS Lett 65: 56-58.
7. Capparelli, R., Parlato, M., Borriello, G., Salvatore, P., and Iannelli, D. (2007) Experimental phage therapy against Staphylococcus aureus in mice. Antimicrob Agents Chemother 51: 2765-2773.
8. Cheng, X., Ming, X., and Croyle, M.A. (2003) PEGylated adenoviruses for gene delivery to the intestinal epithelium by the oral route. Pharm Res 20: 1444-1451.
9. Coligan, J.E., Kruisbeek, A.M., Margulies, D.H., Shevach, E.M., and Strober, W. (2001) Current Protocols in Immunology. New York, NY, USA: John Wiley and Sons.
10. Croyle, M.A., Yu, Y.-C., and Wilson, J.M. (2000) Development of a rapid method for the PEGylation of adenoviruses with enhanced transduction and improved stability under harsh storage conditions. Hum Gene Ther 11: 1713-1722.
11. Croyle, M.A., Chirmule, N., Zhang, Y., and Wilson, J.M. (2001) 'Stealth' adenoviruses blunt cell-mediated and humoral immune responses against the virus and allow for significant gene expression upon readministration in the lung. J Virol 75: 4792-4801.
12. Croyle, M.A., Chirmule, N., Zhang, Y., and Wilson, J.M. (2002) PEGylation of E1-deleted adenovirus vectors allows significant gene expression on readministration to liver. Hum Gene Ther 13: 1887-1900.
13. Croyle, M.A., Callahan, S.M., Auricchio, A., Schumer, G., Linse, K.D., Wilson, J.M., et al. (2004) PEGylation of a vesicular stomatitis virus G pseudotyped Lentivirus vector prevents inactivation in serum. J Virol 78: 912-921.
14. Croyle, M.A., Le, H.T., Linse, K.D., Cerullo, V., Toietta, G., Beaudet, A., and Pastore, L. (2005) PEGylated helper-dependent adenoviral vectors: highly efficient vectors with an enhanced safety profile. Gene Ther 12: 579-587.
15. Delgado, C., Patel, J.N., Francis, G.E., and Fisher, D. (1990) Coupling of poly(ethylene glycol) to albumin under very mild conditions by activation with tresyl chloride: characterization of the conjugate by partitioning in aqueous two-phase systems. Biotech Appl Biochem 12: 119-128.
16. Farber, P.A. (1969) Blood clearance of bacteriophage phi-X 174 in mice: effect of immunosuppressive drugs. Can J Microbiol 15: 1465-1467.
17. Felix, A., and Callow, B.R. (1943) Typing of paratyphoid B. bacilli by means of Vi bacteriophage. Brit Med J 2: 127-130.
18. Graham, L.M. (2003) PEGASPARAGINASE: a review of clinical studies. Adv Drug Deliv Rev 55: 1293-1302.
19. Inchley, C.J. (1969) The activity of mouse Kupffer cells following intravenous injection of T4 bacteriophage. Clin Exp Immunol 5: 173-187.
20. Katre, N.V. (1993) The conjugation of protein with polyethylene glycol and other polymers. Adv Drug Deliv Rev 10: 91-114.
21. Lee, G.K., Maheshri, N., Kaspar, B., and Schaffer, D.V. (2005) PEG conjugation moderately protects adeno-associated viral vectors against antibody neutralization. Biotech Bioeng 92: 24-34.
22. Levy, Y., Hershfield, M.S., Fernandez-Mejia, C., Polmar, S.H., Scudiery, D., Berger, M., and Sorensen, R.U. (1988) Adenosine deaminase deficiency with late onset of recurrent infections: response to treatment with polyethylene glycol-modified adenosine deaminase. J Pediatr 113: 312-317.
23. Loessner, M.J., and Busse, M. (1990) Bacteriophage typing of Listeria species. Appl Environ Microbiol 56: 1912-1918.
24. McVay, C.S., Velasquez, M., and Fralick, J.A. (2007) Phage therapy of Pseudomonas aeruginosa infection in a mouse burn wound model. Antimicrob Agents Chemother 51: 1934-1938.
25. Merril, C.R., Biswas, B., Carlton, R., Jensen, N.C., Creed, G.J., Zullo, S., and Adhya, S. (1996) Long-circulating bacteriophage as antibacterial agents. Proc Natl Acad Sci USA 93: 3188-3192.
26. Merril, C.R., Scholl, D., and Adhya, S.L. (2003) The prospect for bacteriophage therapy in Western medicine. Nat Rev Drug Discov 2: 489-497.
27. Mok, H., Palmer, D.J., Ng, P., and Barry, M.A. (2004) Evaluation of polyethylene glycol modification of first-generation and helper-dependent adenoviral vectors to reduce innate immune responses. Mol Ther 11: 66-79.
28. O'Riordan, C.R., Lachapelle, A., Delgado, C., Parkes, V., Wadsworth, S.C., Smith, A.E., and Francis, G.E. (1999) PEGylation of adenovirus with retention of infectivity and protection from neutralizing antibody in vitro and in vivo. Hum Gene Ther 10: 1349-1358.
29. Reddy, K.R., Modi, M.W., and Pedder, S. (2002) Use of peginterferon alfa-2a (40 kD) (Pegasys®) for the treatment of hepatitis C. Adv Drug Deliv Rev 54: 571-586.
30. Roberts, M.J., Bentley, M.D., and Harris, J.M. (2002) Chemistry for peptide and protein PEGylation. Adv Drug Deliv Rev 54: 459-476.
31. Sambrook, J., and Russell, D.W. (2001) Molecular Cloning: A Laboratory Manual, 3rd edn. New York, NY, USA: Cold Spring Harbor Laboratory Press.
32. Scott, M.D., Murad, K.L., Koumpouras, F., Talbot, M., and Eaton, J.W. (1997) Chemical camouflage of antigenic determinants: stealth erythrocytes. Proc Natl Acad Sci USA 94: 7566-7571.
33. Seeliger, H.P.R., and Holl, K.M. (1961) Die Verwendung des Salmonella-O1 Phagen bei der Differential-Diagnose von Enterobacteriaceen. Zschr Hyg 147: 529-538.
34. Sulakvelidze, A., Alavidze, Z., and Morris, J.G., Jr (2001) Bacteriophage therapy. Antimicrob Agents Chemother 45: 649-659.
35. Verbeken, G., De Vos, D., Vaneechoutte, M., Merabishvili, M., Zizi, M., and Pirnay, F.P. (2007) European regulatory conundrum of phage therapy. Future Microbiol 2: 485-491.
36. Zink, R., and Loessner, M.J. (1992) Classification of virulent and temperate bacteriophages of Listeria spp. on the basis of morphology and protein analysis. Appl Environ Microbiol 58: 296-302.